Roger S. Newton, Director at Esperion Therapeutics, Inc. (ESPR), sold 17,700 shares at $53.68 ($904K) on 2018-08-27, disclosed to the SEC on 2018-08-29.
Open-market sale of $904k ESPR by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $50.65 | 12,100 | $613K | 67.8% |
| 2 | $51.46 | 4,200 | $216K | 23.9% |
| 3 | $52.91 | 700 | $37K | 4.1% |
| 4 | $53.68 | 700 | $38K | 4.2% |
| Total | $51.05 avg | 17,700 | $904K | 100% |
| Filing → |
| ESPR | SELL | 2018-10-18 | $1.7M | — | Filing → |
| ESPR | SELL | 2018-08-22 | $365K | — | Filing → |
| ESPR | SELL | 2018-03-29 | $1.8M | — | Filing → |